ClinicalTrials.gg
Not yet recruitingNCT07721051Updated Jul 22, 2026

The Effect of Using Different Scaffolds in Retreated Teeth on The Clinical and Radiological Success of Regenerative Endodontic Treatment

An observational study in Endodontics, Regenerative Endodontic Procedures and PRF, sponsored by Kırıkkale University. Not yet recruiting. Open to participants aged 16 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by Kırıkkale University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
60
Ages
16 Years to 40 Years
Sex
All
01

Study summary

This clinical study aims to compare the clinical and radiographic outcomes of four different scaffolds used in regenerative endodontic treatment of previously root canal-treated permanent teeth requiring retreatment.

Participants will be randomly assigned to one of four groups based on the scaffold used: induced blood clot, injectable platelet-rich fibrin (i-PRF), advanced platelet-rich fibrin (A-PRF), or advanced platelet-rich fibrin plus (A-PRF+). All participants will receive the same root canal disinfection and restorative procedures, with the scaffold type differing between the groups.

Participants will be evaluated clinically and radiographically at 3, 6, and 12 months after treatment. The study will compare the groups in terms of the resolution of clinical signs and symptoms and changes observed on radiographic and cone-beam computed tomography images.

Read the detailed description

This study was designed as a prospective, controlled clinical trial to compare the clinical and radiographic outcomes of four regenerative endodontic approaches applied to permanent teeth requiring single-root retreatment. The sample size was calculated using G*Power v3.1 (Heinrich Heine University, Düsseldorf, Germany) based on an effect size of 0.50, a significance level of 0.05, and a power of 0.80; a total of 60 patients, with 15 patients per group, were planned to be included in the study. The null hypothesis (H0) of this study is that there will be no difference in the clinical and radiographic success of four different regenerative approaches (apically induced blood clot, injected i-PRF, A-PRF, and A-PRF+) applied to necrotic permanent teeth requiring single-root retreatment. The necessary institutional approval and ethics committee approval have been obtained for this study. Patient participation will be voluntary; patients will be informed about the study, and informed consent forms will be obtained from those who wish to participate. Following the application of local anesthesia and a rubber dam, the relevant teeth will be disinfected with 2.5% NaOCl, and the general shape of the cavity will be formed using a sterile diamond bur with a high-speed, water-cooled air turbine. If caries is present, sterile steel burs attached to a low-speed micromotor and an angle piece will be used to remove it. Once the access cavity is complete, the root canal filling material will be removed with retreatment files without chemical agents. The working length will be determined, and mechanical preparation will be kept to a minimum. The apical opening will be enlarged to a diameter equal to the tip diameter of a #40 file. For root canal irrigation, 20 mL of 1.5% sodium hypochlorite, 20 mL of normal saline, and 10 mL of 17% EDTA will be used. After calcium hydroxide is placed in the root canal, the tooth will be sealed with a temporary filling material. Second Session (3 weeks later): If there are no symptoms, the temporary filling material and calcium hydroxide will be removed. A final irrigation will be performed with 20 mL of 17% EDTA. The volunteer patients included in the study will be divided into four groups according to the random assignment determined on the www.randomizer.org website.

Group 1: (Blood Clot Group) Bleeding will be induced by exiting the apical foramen with sterile Type K files to ensure the canal is filled with blood.

Group 2: (i-PRF Group) 10 cc of venous blood drawn from the patient's antecubital vein will be centrifuged at 700 rpm for 3 minutes. The upper yellow layer will be drawn up with a syringe and injected into the root canal.

Group 3: (A-PRF group) The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1500 rpm for 14 minutes. The upper yellow layer will be removed from the tube and applied to the root canal using sterile pluggers.

Group 4: (A-PRF+ group) The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1300 rpm for 8 minutes. The yellow layer on top will be removed from the tube and applied to the canal using sterile applicators.

In all groups, after a bioceramic-based covering material is placed over the scaffold, a glass ionomer base material will be applied, and the teeth will be restored with a bonding agent and composite. Post-treatment, periapical X-rays will be taken of all patients, and a KIBT scan will be performed. Patients will be evaluated clinically and radiographically at 3-, 6-, and 12-month follow-up visits. The clinical evaluation will assess spontaneous pain, percussion sensitivity, palpation sensitivity, the presence of a fistula, and mobility. Vitality tests will be performed using a cold test and an electrical pulp test. At the 12-month follow-up, a KIBT scan will be performed to examine changes in lesion size, root wall thickness, or hard tissue formation.

Measurement of Dentin Thickness KIBT images will be acquired using an I-CAT (Imaging Sciences, Hatfield, PA, USA) tomography device in accordance with the standard imaging protocol. During imaging, the Frankfurt horizontal plane will be positioned parallel to the floor. In contrast, the midsagittal plane will be positioned perpendicular to the floor using the jaw support unit and laser alignment beams. Images will be acquired using standard parameters: an 8x8 cm field of view (FOV) of the relevant jaw, 120 kVp, 8 mA, a voxel size of 0.25 mm³, and a scan time of 14.7 seconds. Dentin thickness measurements for the relevant tooth will be performed on axial sections. Measurements will be determined in millimeters at three regions-4, 6, and 8 mm from the radiographic apex-based on the distance between the root canal wall and the external root surface.

Root Canal Volume Measurement Root canal volume measurements for the teeth will be performed using the ITK-SNAP software. KIBT images will be imported into the program in DICOM format. The region of interest will be delineated as a rectangular area using a semi-automatic segmentation method. During segmentation of all images, the minimum and maximum threshold values will be optimized based on the gray density distribution. Minimal manual adjustments will be made for each tooth as necessary. A region-growing algorithm will be applied, and a manual spread point will be placed at the root canal midpoint. The segmentation process will spread outward from the selected spread point and automatically terminate when it exceeds the predefined threshold boundaries. Segmentation areas extending beyond the anatomical boundaries will be manually corrected. The resulting volume values will be recorded in mm³ via the software's "Volume and Statistics" tab.

Measurement of Periapical Lesion Dimensions Periapical lesion dimensions will be assessed in millimeters along three axes. The bucco-lingual and mesio-distal widths of the lesion will be measured on the axial section where the lesion appears widest. The vertical dimension will be determined from the sagittal section at which the lesion appears widest.

Statistical Analysis All data will be analyzed using SPSS Statistics 17.0 for Windows (SPSS Inc., Chicago, IL), and a P-value of \< 0.05 will be considered statistically significant. Lesion size and dentin thickness will be analyzed using a t-test. Volumetric changes in the root canal before and after regenerative endodontic treatment will be tested using the Wilcoxon signed-rank test.

02

Conditions studied

  • Endodontics
  • Regenerative Endodontic Procedures
  • PRF
  • i-PRF
  • Retreatment
  • A-PRF
  • A-PRF Plus

Keywords

  • Regenerative endodontic procedures
  • retreatment
  • A-PRF
  • A-PRF plus
  • i-PRF
03

In context

Lead sponsor

Kırıkkale University is the lead sponsor of 114 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This study will include patients aged 16-40 with single-canal, closed-apical permanent teeth who presented to the Department of Endodontics at the Faculty of Dentistry, Kırıkkale University, for endodontic retreatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 16-40 who are systemically healthy
  • Patients who have a permanent tooth with a single root canal and fully developed root that requires retreatment
  • Patients who may or may not have periapical radiolucency

Exclusion criteria

Exclusion Criteria:

  • Patients who require antibiotic prophylaxis
  • Patients with systemic conditions such as diabetes or hematological disorders
  • Patients who have taken antibiotics, anti-inflammatory medications, and/or antidepressants within the past three weeks
  • Patients who are pregnant or suspect they may be pregnant during treatment
  • Patients with heavy plaque and tartar buildup on their teeth
  • Patients with redness and bleeding of the gums
  • Patients with severe gingivitis, generalized periodontitis, or a periodontal pocket depth of more than 3 mm
  • Patients with internal or external root resorption
  • Patients for whom complete isolation with a rubber dam cannot be achieved
  • Patients with an open, immature root apex
  • Patients with horizontal or vertical fractures
  • Patients with teeth having multiple roots or root canals
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Blood clot group

    Bleeding will be induced by removing the apical opening with sterile Type K files to ensure the canal fills with blood. The blood clot induced apically will be used as the scaffold material.

  • i-PRF group

    10 cc of venous blood drawn from the patient's antecubital vein will be centrifuged at 700 rpm for 3 minutes. The yellow layer on top will be drawn up with a syringe and injected into the canal. i-PRF will be used as the scaffold material.

  • A-PRF group

    The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1500 rpm for 14 minutes. The yellow layer on top will be removed from the tube and applied into the canal using sterile applicators. A-PRF will be used as the scaffold material.

  • A-PRF+ group

    As in Group 2, 10 cc of venous blood will be centrifuged at 1300 rpm for 8 minutes. The yellow layer on top will be removed from the tube and applied into the canal using sterile pluggers. A-PRF+ will be used as the scaffold material.

06

What researchers measure

Primary outcomes

  1. Proportion of Teeth Achieving Clinical and Radiographic Success at 12 Months

    Clinical and radiographic success will be assessed as a composite binary outcome for each treated tooth at the 12-month follow-up. A tooth will be classified as successful if both clinical and radiographic success criteria are met. Clinical success will be defined as the absence of spontaneous pain, tenderness to percussion, tenderness to palpation, swelling, sinus tract, and pathological mobility. Radiographic success will be defined as reduction or complete resolution of the baseline periapical lesion without the development of a new periapical lesion. The outcome will be reported as the proportion of teeth achieving clinical and radiographic success at 12 months.

    Time frame: 12 months after treatment

Secondary outcomes

  1. CBCT-Based Change in Aggregate Periapical Lesion Size From Baseline to 12 Months

    Periapical lesion size will be assessed on cone-beam computed tomography images at baseline and at the 12-month follow-up. The mesiodistal, buccolingual, and vertical dimensions of the lesion will be measured in millimeters. These three linear measurements will be summed to obtain one aggregate periapical lesion size value for each tooth. The change in aggregate periapical lesion size from baseline to 12 months will be compared among the scaffold groups.

    Time frame: From baseline to 12 months after treatment

  2. CBCT-Based Change in Mean Dentinal Wall Thickness From Baseline to 12 Months

    Dentinal wall thickness will be measured in millimeters on cone-beam computed tomography images at baseline and at the 12-month follow-up. Measurements will be performed at predefined levels from the radiographic apex, and the mean of these measurements will be calculated to obtain one dentinal wall thickness value for each tooth. The change in mean dentinal wall thickness from baseline to 12 months will be compared among the scaffold groups.

    Time frame: From baseline to 12 months after treatment

  3. CBCT-Based Change in Root Canal Volume From Baseline to 12 Months

    Root canal volume will be measured in cubic millimeters on cone-beam computed tomography images at baseline and at the 12-month follow-up using image analysis software. The change in root canal volume from baseline to 12 months will be compared among the scaffold groups.

    Time frame: From baseline to 12 months after treatment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07721051
Responsible party
Ali Erdemir (Professor doctor, Kırıkkale University) — Principal investigator
First posted
Jul 22, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 1, 2027 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Jul 22, 2026

Study contacts

ALİ ERDEMİR, Professor
Contact
erdemirali@hotmail.com
+905325650065
Sara NAJJARİ HAGH
Contact
saranajjari1998@gmail.com
+905525981520

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion